Federal Register / Vol. 65, No. 221 / Wednesday, November 15, 2000 / Notices 69035

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Human

Genome Research Institute Initial Review

Group, Ethical, Legal, Social Implications

Review Committee.

Date: December 5, 2000.

Time: 1:00 pm to 3:00 pm.

Agenda: To review and evaluate grant

applications.

Place: National Human Genome Research

Institute, National Institutes of Health,

Building 31, Room B2B32, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Rudy O. Pozzatti, PhD,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301 402–0838.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.172, Human Genome

Research, National Institutes of Health, HHS)

Dated: November 3, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29140 Filed 11–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: November 28, 2000.

Time: 8:3 am to 5:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Sheraton Premiere at Tyson’s

Corner, 8661 Leesburg Pike, Vienna, VA

22182.

Contact Person: Susan M. Matthews,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6134, MSC 9607,

Bethesda, MD 20892–9607, 301–443–5047.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: November 6, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29130 Filed 11–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: December 4, 2000.

Time: 8:30 am to 10:30 am.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Henry J. Haigler, PhD,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Rm. 6150, MSC 9608,

Bethesda, MD 20892–9608, 301/443–7216.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: November 6, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29133 Filed 11–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the National Institute of

Mental Health Special Emphasis Panel,

December 4, 2000, 8:30 am to December

4, 2000, 5:00 pm, Bethesda Holiday Inn,

8120 Wisconsin Avenue, Bethesda, MD,

20814 which was published in the

Federal Register on October 25, 2000,

65 FR 63878.

The meeting time has been changed to

10:30 am to 6:00 pm on the same day

at the same hotel. The meeting is closed

to the public.

Dated: November 6, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29134 Filed 11–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: December 1, 2000.